Literature DB >> 7726635

In vitro genetically aberrant T-cell clones with continuous growth are associated with atopic dermatitis.

K Kaltoft1, C B Pedersen, B H Hansen, A S Lemonidis, J Frydenberg, K Thestrup-Pedersen.   

Abstract

Atopic dermatitis is a disease with a genetic predisposition affecting the immune system, with T lymphocytes participating in the immune dysregulation. Most in vitro T lymphocyte studies of atopic dermatitis have focused on antigen-specific T-cell clones. However, antigen-non-specific regulatory T lymphocytes may also take part in the pathway leading to antigen-specific clonal T-lymphocyte proliferation. T lymphocytes from skin biopsy specimens from three patients with severe atopic dermatitis were cultured in the presence of IL-2 and IL-4, but without antigen added. Initially, proliferation was oligo- or polyclonal, but in all cases overgrowth by T cells with clonal chromosomal aberrations was subsequently observed. These abnormal T-cell clones demonstrated continuous growth and complete or partial phenotypic loss of the T-cell antigen receptor complex. In summary, these findings suggest that a subset of aberrant skin-homing T lymphocytes is associated with atopic dermatitis.

Entities:  

Mesh:

Year:  1994        PMID: 7726635     DOI: 10.1007/bf00370717

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  8 in total

1.  Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides.

Authors:  K Kaltoft; S Bisballe; T Dyrberg; E Boel; P B Rasmussen; K Thestrup-Pedersen
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

2.  Human T lymphocytes possess a limited in vitro life span.

Authors:  N L Perillo; R L Walford; M A Newman; R B Effros
Journal:  Exp Gerontol       Date:  1989       Impact factor: 4.032

3.  Interleukin-4 promotes the expansion of skin-infiltrating lymphocytes from atopic dermatitis in vitro.

Authors:  U Reinhold; S Kukel; B Goeden; U Neumann; W Wehrmann; H W Kreysel
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

4.  Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis.

Authors:  A W Jensen; M Hokland; H Jørgensen; J Justesen; J Ellegaard; P Hokland
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

Review 5.  Cytogenetic findings in cell lines from cutaneous T-cell lymphoma.

Authors:  K Kaltoft; B H Hansen; K Thestrup-Pedersen
Journal:  Dermatol Clin       Date:  1994-04       Impact factor: 3.478

6.  Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative "helper" T cell clones.

Authors:  G Pawelec; E M Schneider; P Wernet
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

Review 7.  Atopic dermatitis: recent trends in pathogenesis and therapy.

Authors:  K D Cooper
Journal:  J Invest Dermatol       Date:  1994-01       Impact factor: 8.551

Review 8.  Immune dysregulation in atopic eczema.

Authors:  J D Bos; E A Wierenga; J H Sillevis Smitt; F L van der Heijden; M L Kapsenberg
Journal:  Arch Dermatol       Date:  1992-11
  8 in total
  1 in total

Review 1.  Emerging Nanomedicines for the Treatment of Atopic Dermatitis.

Authors:  Khushali Parekh; Tejal A Mehta; Namdev Dhas; Pavan Kumar; Amirali Popat
Journal:  AAPS PharmSciTech       Date:  2021-01-24       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.